Vicky Sevillano
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, PARP inhibition in cancer therapy, Epigenetics and DNA Methylation, Silicon Carbide Semiconductor Technologies
Most-Cited Works
- → Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target(2009)115 cited
- → 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma(2011)114 cited
- → The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin(2015)98 cited
- → Cyclin D3 gene amplification in bladder carcinoma in situ(2010)22 cited
- → Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin(2017)1 cited
- → 131 Relevance of copy number alterations in Ewing Sarcoma: gain of 1q defines a subset of patients with worse outcome, probably caused by DTL/CDT2 overexpression and subsequent cell cycle deregulation(2010)